Screener
Perspective Therapeutics CATX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
FAQ
- What is Perspective Therapeutics's net income?
- Perspective Therapeutics (CATX) reported net income of -$26.79M in Q2 2026.
- How has Perspective Therapeutics's net income changed year-over-year?
- Perspective Therapeutics's net income decreased by 24.7% year-over-year, from -$21.49M to -$26.79M.
- What is the long-term trend for Perspective Therapeutics's net income?
- Over 4 years (2021 to 2025), Perspective Therapeutics's net income has grown at a 106.7% compound annual growth rate (CAGR), from -$5.65M to -$103.12M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Perspective Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude